
Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
Mirati Therapeutics Announces Pricing of Public Offering of Common Stock
-
Mirati Therapeutics (MRTX) Announces Proposed $500M Share Offering
-
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
-
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
-
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 4.33M Share Common Offering at $202/Sh
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Mirati Therapeutics (MRTX) Announces $700M Proposed Public Offering of Common Stock
-
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
-
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 3.076M Share Common Offering at $97.50/Sh
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Pre-Open Stock Movers 01/09: (AXNX) (CHS) (DBVT) Higher (TUFN) (BBBY) (AYI) Lower (more...)
-
Mirati Therapeutics (MRTX) Announces Proposed Public Offering of $250M of Common Stock
-
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
-
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 2.1M Shares at $97
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Mirati Therapeutics (MRTX) Announces Proposed Common Share Offering
-
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
-
Mirati Therapeutics (MRTX) Highlighted At Cowen As A Best SMidcap Idea
-
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
-
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 1.61M Share Offering at $62/Sh
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Mirati Therapeutics (MRTX) Announces Proposed $75M Share Common Offering
-
Mirati Therapeutics Announces Proposed Public Offering Of Common Stock
-
Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 2.75M Common Stock Offering at $38.85/Share
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Mirati Therapeutics (MRTX) Plans Public Offering of Common Stock
-
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
-
Mirati Therapeutics To Present At Upcoming Healthcare Conferences
-
Cowen Starts Mirati Therapeutics (MRTX) at Outperform
-
Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Mirati Therapeutics (MRTX) Prices 2M Offering of Common Stock at $13/Share
-
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock
-
Mirati Therapeutics (MRTX) Plans Public Offering Of Common Stock
-
Mirati Therapeutics Announces Proposed Public Offering Of Common Stock
-
Notable Analyst Rating Changes 6/6: (RF) (WFT) (WMT) Upgraded; (ABBV) (CUDA) (HOG) Downgraded
-
Pre-Open Stock Movers 06/06: (VBLT) (YGE) (ONTY) Higher; (DNAI) (ADMP) (MRTX) Lower (more...)